Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation. Since 2010, we invest in pioneering science that offers the potential to provide a significant benefit for our patients. Since innovation is not restricted by geography, we invest worldwide.
